2014
DOI: 10.14748/bmr.v25.1048
|View full text |Cite
|
Sign up to set email alerts
|

New approach in the treatment of ophthalmic neovascular disorders: using fusion protein aflibercept

Abstract: The aim of this review is to appraise the usage of a newly approved anti-vascular endothelial growth factor (anti-VEGF) fu-

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2015
2015
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 21 publications
0
1
0
1
Order By: Relevance
“…Приложението му върху мишки с индуцирана ендометриоза показва инхибиране на ендометриозните лезии, като намалява клетъчната пролиферация и стимулира апоптозата (80). Други възможности за повлияване на VEGF е чрез използване на фузионния протеин aflibercept (81).…”
Section: нехормонални терапевтични възможностиunclassified
“…Приложението му върху мишки с индуцирана ендометриоза показва инхибиране на ендометриозните лезии, като намалява клетъчната пролиферация и стимулира апоптозата (80). Други възможности за повлияване на VEGF е чрез използване на фузионния протеин aflibercept (81).…”
Section: нехормонални терапевтични възможностиunclassified
“…25 Among the recent contributions to the study of the problem, we should single out that by the Bulgarian scholar Pavel Georgiev in 2001. 26 Georgiev revisited the argumentation in the earlier literature, discussed the use and character of the patriarchal epirriptarion, and discovered an instance of Byzantine imperial coronation ceremony that fits more closely than any other with what our sources succinctly indicated about that of 913. This ceremony, described in an anonymous account of the enthronement of Manuel II Palaiologos (1391-1425) as senior emperor in 1391, constituted a blessing and confirmation (apokatastasis) of an emperor who had already been crowned on a previous occasion.…”
mentioning
confidence: 91%